Greer Capital Advisors
We specialize in bridging the equity gap for late and growth-stage companies in our area to build and realize value.
more
>
4.1.11
Tranzyme Pharma Announces IPO Pricing
1.13.11
Cumberland - FDA Approval For New Formulation
10.28.10
Vivo Nets $2M Injection For Stem Cell Research
10.8.10
BioDtech Scores $600,000 in Venture Capital Infusion
10.6.10
Vivo Biosciences - ACEA Biosciences - Roche to develop New xCELLigence System
9.23.10
Cumberland - Cadolor on Formulary at U.S. Medical Centers
8.16.10
Cumberland - Releases Second Quarter 2010 Financial Results
6.16.10
Tranzyme Pharma Announces Licensing Deal With Norgine
4.16.10
Southern Research/Vivo Biosciences - Announce Collaborative Co-marketing Agreement
3.30.10
Cumberland - Acetadote sNDA Submission
3.10.10
Cumberland - Reports 2009 Earnings
3.3.10
Vidacare - Unveils Bone Marrow Extraction Device in U.S.
1.5.10
Volcano - Announces Receipt of CE Mark for OCT Imaging System and Catheter
1.5.10
Cumberland - Caldolor Data Presented at Critical Care Conference - Miami, FL
12.23.09
Halo Announces Partnership with A&D Medical
12.9.09
NashvilleBBJ Cumberland
12.8.09
Tranzyme Pharma Enters into Strategic Drug Discovery Collaboration with Bristol-Myers Squibb
12.1.09
Acetadote Pharmacoeconomic Study Release
11.24.09
Vidacare Set to Launch Biopsy Tool
11.10.09
Cumberland Q3 Financial Results
10.19.09
Caldolor 008A Dose-Ranging Pain Study Publication
10.14.09
Vaxin Launches Joint Venture with AnC Bio in Korea
9.14.09
Wall Street Journal Award Winner Update - Vidacare
more headlines...
© 2003 Greer Capital Advisors LLC
